Reviving Immigration Is Key To U.S. Turnaround: Kotok
David Kotok, Chairman & Chief Investment Officer at Cumberland Advisors, on why markets are looking forward to the end of Trump chaos and covid. Nick Colas, co-Founder of DataTrek Research, on market ...
24 Nov 202026min
The Realignment of Global Dollar Policy Will Boost Gold
Everett Millman, precious metals specialist with Gainesville Coins, on his outlook for gold and precious metals. "Banker to the World" Bill Rhodes, former Chairman of Citibank and President and CEO of...
23 Nov 202029min
Mnuchin: Following Law In Seeking Return of Fed Funds
Bloomberg's Saleha Mohsin, U.S. Treasury reporter, and Mike McKee, International Economics & Policy Correspondent, discuss Treasury Secretary Steven Mnuchin clashing with the Fed over returning unused...
20 Nov 202028min
How to Tweak the 60/40 Portfolio to Boost Yield: Ritholtz
Barry Ritholtz, Founder of Ritholtz Wealth Management, Bloomberg Opinion columnist, and Host of Masters of Business, discusses the 60-40 portfolio. Ataman Ozyildirim, Senior Director, Economics & Glob...
19 Nov 202024min
Boeing Max Is Back, Cash Generation to Return in 2021: Ferguson
George Ferguson, Senior Aerospace, Defense & Airlines Analyst for Bloomberg Intelligence, on Boeing Max cleared to fly by the FAA, and Sarah Ponczek, Bloomberg cross-asset reporter, on markets and ass...
18 Nov 202031min
Get Ready For Another Round Of Toilet Paper Panic
Burt Flickinger, Managing Director at Strategic Resource Group, on retail earnings and why the covid supply shock hasn't improved. Ben Slavin, Global Head of ETFs, Asset Servicing, at BNY Mellon, on t...
17 Nov 202027min
Bonus: Game Changers, Part 3
As the earth is facing an increasingly consequential climate crisis, inquisitive minds all over the globe are hard at work trying to find solutions. Many of them have been able to translate their eure...
17 Nov 202011min
Moderna CEO: 'Game-Changer' Vaccine Is Easier To Ship
Moderna CEO Stephane Bancel speaks with Bloomberg's Alix Steele and Guy Johnson on the company's covid vaccine trials, found to be 94% effective. Sam Fazeli, Senior Pharmaceutical Analyst and Head of ...
16 Nov 202019min
